Medical disclaimer. This page is for tracking and education only. It is not medical advice and it never recommends doses. Talk with your prescriber or care team before you change, lower, or stop any medication. Ozempic, Wegovy, Mounjaro, and Zepbound are named only to describe what readers search for.
What people mean by food noise
People use food noise to describe thoughts about food that feel hard to quiet, such as frequent cravings, extra planning around meals, or feeling mentally pulled toward eating. It is not a formal diagnosis, but it is a common way to describe a change in appetite or preoccupation with food.
If food noise after stopping GLP-1 feels stronger, that does not mean you did something wrong. Appetite and food thoughts can change for many reasons, including the change itself, sleep, stress, and routine.
In the STEP 1 extension of semaglutide 2.4 mg, participants had lost 17.3% of body weight by week 68, then regained 11.6 percentage points of it about a year after stopping, which was about two thirds of the prior loss. In SURMOUNT-4, adults who had completed 36 weeks of tirzepatide and then switched to placebo gained 14.0% of body weight from week 36 to week 88, while those who continued tirzepatide lost a further 5.5%.
For a plain-language overview of what people often notice after stopping, see what happens when you stop GLP-1.
What a weekly check-in can show
A weekly check-in can help you notice whether food noise is steady, rising, or linked to other changes. The app will have a weekly appetite check-in from 1, meaning quiet, to 5, meaning loud, so you can track your own pattern over time.
Some people also find it useful to look at trends alongside weight, hunger, meals, and strength work. The app will show a weekly weight trend with an adjustable regain band, and it will include a strength log that aims to make it easier to notice whether you are doing about 2 to 3 sessions a week.
If you want to see a related tool, the app will have an appetite check-in feature designed for simple tracking rather than judgment.
A check-in is not a diagnosis and it does not tell you what to do with your medication. It can only help you and your clinician see patterns that are otherwise easy to miss.
Habits that people discuss with clinicians: sleep, protein, fiber
People often ask their clinician about daily habits that may make food thoughts feel easier to manage. Sleep is one common topic, because poor sleep can make appetite feel harder to read. Protein and fiber are also common topics because they can change how full a meal feels.
The app will let users set protein and fiber targets from body weight, but it will not tell anyone what to eat or how to eat. If eating feels hard, or if meals are becoming stressful, talk with a clinician or dietitian for personalized guidance.
If appetite is low or meals feel complicated, some people look for simple options. You can browse meal ideas for low appetite for general ideas to discuss with your care team.
Keeping track of these habits can be useful, but it is not a promise. A change in sleep, protein, or fiber may help you notice what affects your food noise, yet the best next step still belongs with your prescriber or care team.
When to talk to your care team
Talk to your care team if food noise after stopping GLP-1 is making daily life harder, if eating feels stressful, or if you are unsure how to interpret a change in appetite or weight trend. They can help you decide what matters most for your situation.
It is especially useful to reach out if you notice that hunger, food thoughts, or meal patterns are changing quickly, or if you want help reviewing the records you have collected. The app is planned to store data on the device, with no account, and to let you export and delete everything.
The goal is not to judge your eating. It is to notice what is happening and bring that information to a clinician who knows your history.
Join the iOS waitlist from Get the app.
Key facts
- In the STEP 1 extension (2022), people regained 11.6 of the 17.3 percentage points they had lost, about two thirds, within a year of stopping semaglutide. Source
- In SURMOUNT-4 (JAMA 2024), from week 36 to week 88 people switched to placebo gained 14.0% of body weight, while those who continued tirzepatide lost a further 5.5%. Source
Sources
Last updated: